Review



circrna expression microarray slide arraystar human circrna array v2 [8 × 15 k]  (Arraystar inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Arraystar inc circrna expression microarray slide arraystar human circrna array v2 [8 × 15 k]
    Primer details for quantitative real-time reverse transcription–polymerase chain reaction of <t> circRNA_000585. </t>
    Circrna Expression Microarray Slide Arraystar Human Circrna Array V2 [8 × 15 K], supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/circrna+expression+microarray+slide+arraystar+human+circrna+array+v2+%5B8+%C3%97+15+k%5D/pmc08246500-76-33-37?v=Arraystar+inc
    Average 90 stars, based on 1 article reviews
    circrna expression microarray slide arraystar human circrna array v2 [8 × 15 k] - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Potential mechanism of circRNA_000585 in cholangiocarcinoma"

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    Journal: The Journal of International Medical Research

    doi: 10.1177/03000605211024501

    Primer details for quantitative real-time reverse transcription–polymerase chain reaction of  circRNA_000585.
    Figure Legend Snippet: Primer details for quantitative real-time reverse transcription–polymerase chain reaction of circRNA_000585.

    Techniques Used: Reverse Transcription Polymerase Chain Reaction, Sequencing, Amplification

    Heatmap of circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens (P1–3) and matched para-cancer specimens (C1–3) from three patients with CCA. Each block represents different circRNA expression levels (red represents high expression; green represents low expression).
    Figure Legend Snippet: Heatmap of circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens (P1–3) and matched para-cancer specimens (C1–3) from three patients with CCA. Each block represents different circRNA expression levels (red represents high expression; green represents low expression).

    Techniques Used: RNA Expression, Blocking Assay, Expressing

    Fold change in circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens and matched para-cancer specimens from three patients with CCA. (A) scatter plot (dots above the upper line represent fold-change >1.5, dots below the lower line represent fold-change >–1.5); and (B) volcano plot of circRNA expression (red dots represent fold-change >1.5 or >–1.5).
    Figure Legend Snippet: Fold change in circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens and matched para-cancer specimens from three patients with CCA. (A) scatter plot (dots above the upper line represent fold-change >1.5, dots below the lower line represent fold-change >–1.5); and (B) volcano plot of circRNA expression (red dots represent fold-change >1.5 or >–1.5).

    Techniques Used: RNA Expression, Expressing

    Vertical scatter plot showing elevated circRNA_000585 expression in cholangiocarcinoma (CCA) tumour tissue versus matched para-cancer tissue from 15 patients with CCA (central horizontal line represents mean, upper and lower horizonal lines represent SD; P = 0.003 between groups).
    Figure Legend Snippet: Vertical scatter plot showing elevated circRNA_000585 expression in cholangiocarcinoma (CCA) tumour tissue versus matched para-cancer tissue from 15 patients with CCA (central horizontal line represents mean, upper and lower horizonal lines represent SD; P = 0.003 between groups).

    Techniques Used: Expressing

    Association between  circRNA_000585  expression and clinicopathological characteristics in 15 patients with cholangiocarcinoma.
    Figure Legend Snippet: Association between circRNA_000585 expression and clinicopathological characteristics in 15 patients with cholangiocarcinoma.

    Techniques Used: Expressing



    Similar Products

    90
    Arraystar inc circrna expression microarray slide arraystar human circrna array v2 [8 × 15 k]
    Primer details for quantitative real-time reverse transcription–polymerase chain reaction of <t> circRNA_000585. </t>
    Circrna Expression Microarray Slide Arraystar Human Circrna Array V2 [8 × 15 K], supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/circrna+expression+microarray+slide+arraystar+human+circrna+array+v2+%5B8+%C3%97+15+k%5D/pmc08246500-76-33-37?v=Arraystar+inc
    Average 90 stars, based on 1 article reviews
    circrna expression microarray slide arraystar human circrna array v2 [8 × 15 k] - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Primer details for quantitative real-time reverse transcription–polymerase chain reaction of  circRNA_000585.

    Journal: The Journal of International Medical Research

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    doi: 10.1177/03000605211024501

    Figure Lengend Snippet: Primer details for quantitative real-time reverse transcription–polymerase chain reaction of circRNA_000585.

    Article Snippet: The labelled cRNA mixture was diluted by adding 25 μl of 2× hybridization buffer, and 50 μl of the hybridization solution was transferred into the gasket slide, which was then assembled onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2 [8 × 15 K]).

    Techniques: Reverse Transcription Polymerase Chain Reaction, Sequencing, Amplification

    Heatmap of circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens (P1–3) and matched para-cancer specimens (C1–3) from three patients with CCA. Each block represents different circRNA expression levels (red represents high expression; green represents low expression).

    Journal: The Journal of International Medical Research

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    doi: 10.1177/03000605211024501

    Figure Lengend Snippet: Heatmap of circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens (P1–3) and matched para-cancer specimens (C1–3) from three patients with CCA. Each block represents different circRNA expression levels (red represents high expression; green represents low expression).

    Article Snippet: The labelled cRNA mixture was diluted by adding 25 μl of 2× hybridization buffer, and 50 μl of the hybridization solution was transferred into the gasket slide, which was then assembled onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2 [8 × 15 K]).

    Techniques: RNA Expression, Blocking Assay, Expressing

    Fold change in circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens and matched para-cancer specimens from three patients with CCA. (A) scatter plot (dots above the upper line represent fold-change >1.5, dots below the lower line represent fold-change >–1.5); and (B) volcano plot of circRNA expression (red dots represent fold-change >1.5 or >–1.5).

    Journal: The Journal of International Medical Research

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    doi: 10.1177/03000605211024501

    Figure Lengend Snippet: Fold change in circular (circ)RNA expression levels in cholangiocarcinoma (CCA) tumour specimens and matched para-cancer specimens from three patients with CCA. (A) scatter plot (dots above the upper line represent fold-change >1.5, dots below the lower line represent fold-change >–1.5); and (B) volcano plot of circRNA expression (red dots represent fold-change >1.5 or >–1.5).

    Article Snippet: The labelled cRNA mixture was diluted by adding 25 μl of 2× hybridization buffer, and 50 μl of the hybridization solution was transferred into the gasket slide, which was then assembled onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2 [8 × 15 K]).

    Techniques: RNA Expression, Expressing

    Vertical scatter plot showing elevated circRNA_000585 expression in cholangiocarcinoma (CCA) tumour tissue versus matched para-cancer tissue from 15 patients with CCA (central horizontal line represents mean, upper and lower horizonal lines represent SD; P = 0.003 between groups).

    Journal: The Journal of International Medical Research

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    doi: 10.1177/03000605211024501

    Figure Lengend Snippet: Vertical scatter plot showing elevated circRNA_000585 expression in cholangiocarcinoma (CCA) tumour tissue versus matched para-cancer tissue from 15 patients with CCA (central horizontal line represents mean, upper and lower horizonal lines represent SD; P = 0.003 between groups).

    Article Snippet: The labelled cRNA mixture was diluted by adding 25 μl of 2× hybridization buffer, and 50 μl of the hybridization solution was transferred into the gasket slide, which was then assembled onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2 [8 × 15 K]).

    Techniques: Expressing

    Association between  circRNA_000585  expression and clinicopathological characteristics in 15 patients with cholangiocarcinoma.

    Journal: The Journal of International Medical Research

    Article Title: Potential mechanism of circRNA_000585 in cholangiocarcinoma

    doi: 10.1177/03000605211024501

    Figure Lengend Snippet: Association between circRNA_000585 expression and clinicopathological characteristics in 15 patients with cholangiocarcinoma.

    Article Snippet: The labelled cRNA mixture was diluted by adding 25 μl of 2× hybridization buffer, and 50 μl of the hybridization solution was transferred into the gasket slide, which was then assembled onto the circRNA expression microarray slide (Arraystar Human circRNA Array V2 [8 × 15 K]).

    Techniques: Expressing